A critical breakthrough in cancer research is occurring with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently inactivated in several kinds of malignancies, https://thebookmarkid.com/story22065663/vhh-fragments-restore-tumor-suppressor-p53-the-promising-approach-for-cancer-treatment